Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axent Biosciences
Berkeley, CA, USAaxentbiosciences.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Axent Biosciences develops next-generation stem cell therapies using proprietary manufacturing and implantation platforms. The company has received a $4M CIRM grant to develop scalable, high-quality cell therapy for Parkinson’s Disease. As of now, the company remains pre-clinical with no reported clinical trial results.[5][6]
- Therapeutic areas
- OtherNeurology
- Modalities
- Stem cell therapies[1][2][3][6]Cell therapy[5]
- Industry
- Biotech
02
Partnerships
Not explicitly listed; academic partnership with UC Berkeley as spinout [2]funding from CIRM [5]
Beyond the preview
Go deeper on Axent Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Axent Biosciences.